Amid the many issues Congress has on its agenda, 340B is being pushed to the forefront because of the drug industry’s lobbying efforts. The 340B Drug Pricing Program will be up for review in the U.S. Senate’s Health, Education, Labor and Pensions (HELP) Committee hearing on Thursday, March 15. Advocates for 340B have been going to both congressional offices on Capitol …
By The American Hospital Association WASHINGTON, DC (March 1, 2018) – Hospitals of all kinds provide a full range of benefits to their communities. In a new analysis released today, the American Hospital Association (AHA) spotlights how 340B tax-exempt hospitals provided more than $50 billion in total benefits to their communities in 2015 alone, the most recent year for which data is available. …
On January 24th, the New England Journal of Medicine (“NEJM”) published a study linking the 340B program to an increase in hospital-physician consolidation in the specialties of hematology-oncology and suggesting that 340B hospitals do not use program savings to benefit indigent patients. The study focused solely on Disproportionate Share Hospitals (“DSH”) enrolled in the 340B program, but could have implications for other …
rwc340b | by Sarah Blanchard “Recently introduced legislation purporting to reform the 340B program is a wolf in sheep’s clothing,” said Sara J. Dingwall, Pharm.D, BCPS, AAHIVP, President of RWC-340B and Pharmacy Director of an independent HIV/AIDS clinic in Florida called Whole Family Health. “H.R. 4710, otherwise known as the ‘340B PAUSE Act,’ would not just change the 340B program for …
340B Informed January 25, 2018—A recent study published in the New England Journal of Medicine (NEJM)[i] suggests that hospital use of the 340B program is “contrary to the goals of the program,” relying on a finding that there is no evidence of hospitals using 340B savings to expand care or lower mortality among low-income patients. This finding is inconsistent with existing …
AAMC News | Tuesday, January 23, 2018 |by Stacy Weiner, Staff Writer One of the most effective health care programs, 340B comes at no cost to taxpayers. Learn how the program benefits teaching hospitals, patients, and communities. Sam (not his real name) suffers from advanced liver disease, which makes it hard for him to work at times. He can’t afford a …
Powers Law | JANUARY 16, 2018 CONGRESSIONAL REPORT RECOMMENDING CHANGES TO 340B PROGRAM The House Energy and Commerce Committee issued a report (E&C Report) on January 11 that calls for legislative and administrative changes to the 340B program. The report, titled “Review of the 340B Drug Pricing Program,” was released following the Committee’s two-year investigation into the operation and oversight …
Posted in: Legislative 340B – by Rob, PharmD, MS I just reviewed a report on pending legislation from representative Collins (R-NY) that would redefine the 340B patient definition to only allow 340B pricing to be used for uninsured patients. Of course, this was not the intent of congress when 340B was passed in 1992. In fact, we have heard from law makers …
The Jamestown Sun | By JESSE RUE from Bismarck on Jan 17, 2018 at 7:04 a.m. Drive any stretch of highway in North Dakota, and one is struck by the beauty of this state. Still, the freedom we feel when we travel our endless prairies reveals a stark truth: North Dakota has a health care access problem. It’s certainly no secret that …
BY JIM MARTIN, OPINION CONTRIBUTOR | The Hill Today there is much talk about the state of health care in America. Everything from repealing Obamacare to dealing with the opioid epidemic seems to be on everyone’s radars. But one thing that’s not being talked about is the proposed change to a vital drug pricing program that serves vulnerable populations. This …